Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionals

Authors: Mariya Melnychuk, Cecilia Vindrola-Padros, Michael Aitchison, Caroline S. Clarke, Naomi J. Fulop, Claire Levermore, Satish B. Maddineni, Caroline M. Moore, Muntzer M. Mughal, Catherine Perry, Kathy Pritchard-Jones, Angus I. G. Ramsay, David Shackley, Jonathan Vickers, Stephen Morris

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

The centralisation of specialist cancer surgical services across London Cancer and Greater Manchester Cancer, England, may significantly change how patients experience care. These centres are changing specialist surgical pathways for several cancers including prostate, bladder, kidney, and oesophago-gastric cancers, increasing the specialisation of centres and providing surgery in fewer hospitals. While there are potential benefits related to centralising services, changes of this kind are often controversial. The aim of this study was to identify factors related to the centralisation of specialist surgical services that are important to patients, carers and health care professionals.

Methods

This was a questionnaire-based study involving a convenience sample of patient and public involvement (PPI) and cancer health care professional (HCP) sub-groups in London and Greater Manchester (n = 186). Participants were asked to identify which of a list of factors potentially influenced by the centralisation of specialist cancer surgery were important to them and to rank these in order of importance. We ranked and shortlisted the most important factors.

Results

We obtained 52 responses (28% response rate). The factors across both groups rated most important were: highly trained staff; likelihood and severity of complications; waiting time for cancer surgery; and access to staff members from various disciplines with specialised skills in cancer. These factors were also ranked as being important separately by the PPI and HCP sub-groups. There was considerable heterogeneity in the relative ordering of factors within sub-groups and overall.

Conclusions

This study examines and ranks factors important to patients and carers, and health care professionals in order to inform the implementation of centralisation of specialist cancer surgical services. The most important factors were similar in the two stakeholder sub-groups. Planners should consider the impact of reorganising services on these factors, and disseminate this information to patients, the public and health care professionals when deciding whether or not and how to centralise specialist cancer surgical services.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ramsay AIG, Morris S, Hoffman A, Hunter RM, Boaden R, McKevitt C, Perry C, Pursani N, Rudd AG, Turner SJ, Tyrrell PJ, Wolfe CDA, Fulop NJ. Effects of centralizing acute stroke services on stroke care provision in two large metropolitan areas in England. Stroke. 2015;46:2244–51.CrossRefPubMedPubMedCentral Ramsay AIG, Morris S, Hoffman A, Hunter RM, Boaden R, McKevitt C, Perry C, Pursani N, Rudd AG, Turner SJ, Tyrrell PJ, Wolfe CDA, Fulop NJ. Effects of centralizing acute stroke services on stroke care provision in two large metropolitan areas in England. Stroke. 2015;46:2244–51.CrossRefPubMedPubMedCentral
2.
go back to reference Morris S, Hunter RM, Ramsay AIG, Boaden R, McKevitt C, Perry C, Pursani N, Rudd AG, Schwamm LH, Turner SJ, Tyrrell PJ, Wolfe CDA, Fulop NJ. Impact of centralising acute stroke services in English metropolitan areas on mortality and length of hospital stay: difference-in-differences analysis. BMJ. 2014;349(August):g4757.CrossRefPubMedPubMedCentral Morris S, Hunter RM, Ramsay AIG, Boaden R, McKevitt C, Perry C, Pursani N, Rudd AG, Schwamm LH, Turner SJ, Tyrrell PJ, Wolfe CDA, Fulop NJ. Impact of centralising acute stroke services in English metropolitan areas on mortality and length of hospital stay: difference-in-differences analysis. BMJ. 2014;349(August):g4757.CrossRefPubMedPubMedCentral
3.
go back to reference Coupland VH, Lagergren J, Lüchtenborg M, Jack RH, Allum W, Holmberg L, Hanna GB, Pearce N, Møller H. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008. Gut. 2013;62:961–6.CrossRefPubMed Coupland VH, Lagergren J, Lüchtenborg M, Jack RH, Allum W, Holmberg L, Hanna GB, Pearce N, Møller H. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008. Gut. 2013;62:961–6.CrossRefPubMed
4.
go back to reference Nuttall M, van der Meulen J, Phillips N, Sharpin C, Gillatt D, McIntosh G, et al. A systematic review and critique of the literature relating hospital or surgeon volume to health outcomes for 3 urological cancer procedures. J Urol. 2004;172:2145–52.CrossRefPubMed Nuttall M, van der Meulen J, Phillips N, Sharpin C, Gillatt D, McIntosh G, et al. A systematic review and critique of the literature relating hospital or surgeon volume to health outcomes for 3 urological cancer procedures. J Urol. 2004;172:2145–52.CrossRefPubMed
6.
go back to reference National Institute for Clinical Excellence: Improving outcomes in urological cancers 2002. National Institute for Clinical Excellence: Improving outcomes in urological cancers 2002.
7.
go back to reference Department of Health. Executive NHS: guidance on commissioning cancer services: improving outcomes in upper gastro-intestinal cancers. London: Crown; 2001. Department of Health. Executive NHS: guidance on commissioning cancer services: improving outcomes in upper gastro-intestinal cancers. London: Crown; 2001.
8.
go back to reference NHS England. Everyone counts: planning for patients 2014/15 to 2018/19. 2013. NHS England. Everyone counts: planning for patients 2014/15 to 2018/19. 2013.
9.
go back to reference Commissioning Support for London. A model of care for cancer services: clinical paper. London: Commissioning Support for London; 2010. Commissioning Support for London. A model of care for cancer services: clinical paper. London: Commissioning Support for London; 2010.
10.
go back to reference NHS Commissioning Support for London. Cancer services case for change. London: Commissioning Support for London; 2010. NHS Commissioning Support for London. Cancer services case for change. London: Commissioning Support for London; 2010.
11.
go back to reference London Cancer. London cancer specialist services reconfiguration: a case for change in specialist cancer services. London: London Cancer; 2013. London Cancer. London cancer specialist services reconfiguration: a case for change in specialist cancer services. London: London Cancer; 2013.
12.
go back to reference NHS England. Improving specialist cancer and cardiovascular Services in North and East London and West Essex: engagement overview report. London: NHS England; 2014. NHS England. Improving specialist cancer and cardiovascular Services in North and East London and West Essex: engagement overview report. London: NHS England; 2014.
13.
go back to reference NHS Greater Manchester. The Delivery of “ World Class ” Specialist Cancer Surgery Services in the Greater Manchester and Cheshire Cancer System A Framework Commissioning Specification. Manchester: NHS Greater Manchester; 2013. NHS Greater Manchester. The Delivery of “ World Class ” Specialist Cancer Surgery Services in the Greater Manchester and Cheshire Cancer System A Framework Commissioning Specification. Manchester: NHS Greater Manchester; 2013.
14.
go back to reference Fonslow BR, Stein BD, Webb KJ, Xu T, Choi J, Kyu S, JRY I. NIH Public Access, vol. 10; 2013. p. 54–6. Fonslow BR, Stein BD, Webb KJ, Xu T, Choi J, Kyu S, JRY I. NIH Public Access, vol. 10; 2013. p. 54–6.
15.
go back to reference Groux P, Anchisi S, Szucs T. Are cancer patients willing to travel more or further away for a slightly more efficient therapy? Cancer Clin Oncol. 2014;3:2014. Groux P, Anchisi S, Szucs T. Are cancer patients willing to travel more or further away for a slightly more efficient therapy? Cancer Clin Oncol. 2014;3:2014.
16.
go back to reference Exworthy M, Peckham S. Access, choice and travel: implications for health policy. Soc Policy Adm. 2006;40:267–87.CrossRef Exworthy M, Peckham S. Access, choice and travel: implications for health policy. Soc Policy Adm. 2006;40:267–87.CrossRef
17.
go back to reference Fulop NJ, Ramsay AIG, Perry C, Boaden RJ, McKevitt C, Rudd AG, Turner SJ, Tyrrell PJ, Wolfe CDA, Morris S. Explaining outcomes in major system change: a qualitative study of implementing centralised acute stroke services in two large metropolitan regions in England. Implement Sci. 2016;11:80.CrossRefPubMedPubMedCentral Fulop NJ, Ramsay AIG, Perry C, Boaden RJ, McKevitt C, Rudd AG, Turner SJ, Tyrrell PJ, Wolfe CDA, Morris S. Explaining outcomes in major system change: a qualitative study of implementing centralised acute stroke services in two large metropolitan regions in England. Implement Sci. 2016;11:80.CrossRefPubMedPubMedCentral
18.
go back to reference Ryan M, Bate A, Eastmond CJ, Ludbrook A. Use of discrete choice experiments to elicit preferences. Qual Heal Care. 2001;10:i55–60.CrossRef Ryan M, Bate A, Eastmond CJ, Ludbrook A. Use of discrete choice experiments to elicit preferences. Qual Heal Care. 2001;10:i55–60.CrossRef
19.
20.
go back to reference Commissioning Support for London. A model of care for cancer services: Engagement report. London: Commissioning Support for London; 2011. Commissioning Support for London. A model of care for cancer services: Engagement report. London: Commissioning Support for London; 2011.
21.
go back to reference Jones AP, Haynes R, Sauerzapf V, Crawford SM, Zhao H, Forman D. Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer. 2008;44:992–9.CrossRefPubMed Jones AP, Haynes R, Sauerzapf V, Crawford SM, Zhao H, Forman D. Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer. 2008;44:992–9.CrossRefPubMed
22.
go back to reference Salkeld G, Solomon M, Butow P, Short L. Discrete-choice experiment to measure patient preferences for the surgical management of colorectal cancer. Br J Surg. 2005:742–7. Salkeld G, Solomon M, Butow P, Short L. Discrete-choice experiment to measure patient preferences for the surgical management of colorectal cancer. Br J Surg. 2005:742–7.
23.
go back to reference NEL CSU. Equality analysis: specialist cancer and cardiovascular Services in North and East London. London: NEL CSU; 2014. NEL CSU. Equality analysis: specialist cancer and cardiovascular Services in North and East London. London: NEL CSU; 2014.
24.
go back to reference Miners AH, Llewellyn CD, Cooper V, Youssef E, Pollard A, Lagarde M, Sabin C, Nixon E, Sachikonye M, Perry N, Fisher M. A discrete choice experiment to asses people living with HIV;s (PLWHIV’s) preferences for GP or HIV clinic appointments. Sex Transm Infect. https://doi.org/10.1136/sextrans-2016-052643. Miners AH, Llewellyn CD, Cooper V, Youssef E, Pollard A, Lagarde M, Sabin C, Nixon E, Sachikonye M, Perry N, Fisher M. A discrete choice experiment to asses people living with HIV;s (PLWHIV’s) preferences for GP or HIV clinic appointments. Sex Transm Infect. https://​doi.​org/​10.​1136/​sextrans-2016-052643.
25.
go back to reference Mentzakis E, Stefanowska P, Hurley JA. A discrete choice experiment for investigating preferences for funding drugs used to treat orphan diseases: an exploratory study. Heal Econ Policy Law. 2011;6:405–33.CrossRef Mentzakis E, Stefanowska P, Hurley JA. A discrete choice experiment for investigating preferences for funding drugs used to treat orphan diseases: an exploratory study. Heal Econ Policy Law. 2011;6:405–33.CrossRef
26.
go back to reference Altman DG. Practical statistics for medical research. London: Chapman & Hall/CRC; 1991. Altman DG. Practical statistics for medical research. London: Chapman & Hall/CRC; 1991.
27.
go back to reference Landis JR, Koch GG. The measurement ofobserver agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed Landis JR, Koch GG. The measurement ofobserver agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed
28.
go back to reference Sauerzapf VA, Jones AP, Haynes R, Crawford SM, Forman D. Travel time to radiotherapy and uptake of breast-conserving surgery for early stage cancer in northern England. Health Place. 2008;14:424–33.CrossRefPubMed Sauerzapf VA, Jones AP, Haynes R, Crawford SM, Forman D. Travel time to radiotherapy and uptake of breast-conserving surgery for early stage cancer in northern England. Health Place. 2008;14:424–33.CrossRefPubMed
Metadata
Title
Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionals
Authors
Mariya Melnychuk
Cecilia Vindrola-Padros
Michael Aitchison
Caroline S. Clarke
Naomi J. Fulop
Claire Levermore
Satish B. Maddineni
Caroline M. Moore
Muntzer M. Mughal
Catherine Perry
Kathy Pritchard-Jones
Angus I. G. Ramsay
David Shackley
Jonathan Vickers
Stephen Morris
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4137-8

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine